We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEK icon
12276
PUT
Fuel Tech
FTEK
$45.9M
$21K ﹤0.01%
+17,300
New +$22.5K
BGDE
12277
Big Digital Energy Inc
BGDE
$42.7M
$21K ﹤0.01%
162
-347
-68% -$123K
OPTT icon
12278
Ocean Power Technologies
OPTT
$48.1M
$21K ﹤0.01%
+37,692
New +$36.4K
RKDA icon
12279
CALL
Arcadia Biosciences
RKDA
$1.16M
$21K ﹤0.01%
526
+81
+18% +$3.73K
CNTN
12280
Canton Strategic Holdings
CNTN
$188M
$21K ﹤0.01%
+71
New +$28.7K
UCL
12281
uCloudlink Group
UCL
$14.7M
$21K ﹤0.01%
+17,682
New +$20.9K
ONCR
12282
CALL
DELISTED
Oncorus, Inc.
ONCR
$21K ﹤0.01%
+17,000
New +$23.1K
ACOR
12283
DELISTED
Acorda Therapeutics
ACOR
$21K ﹤0.01%
+2,294
New +$40.8K
SCLEW
12284
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$21K ﹤0.01%
90,186
+34,509
+62% +$18.4K
GSV
12285
DELISTED
Gold Standard Ventures Corp.
GSV
$21K ﹤0.01%
67,721
+22,489
+50% +$8.93K
IZEA icon
12286
CALL
IZEA Worldwide
IZEA
$54M
$20K ﹤0.01%
+5,625
New +$24.2K
LPCN icon
12287
PUT
Lipocine
LPCN
$18.5M
$20K ﹤0.01%
1,459
-676
-32% -$10.5K
RNAC icon
12288
PUT
Cartesian Therapeutics
RNAC
$303M
$20K ﹤0.01%
503
+40
+9% +$1.19K
WGS icon
12289
PUT
GeneDx Holdings
WGS
$2.66B
$20K ﹤0.01%
482
-9,506
-95% -$645K
XNET
12290
Xunlei
XNET
$321M
$20K ﹤0.01%
12,935
-53,137
-80% -$75.5K
XTNT icon
12291
Xtant Medical Holdings
XTNT
$47.4M
$20K ﹤0.01%
+38,824
New +$23K
GOEV
12292
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$20K ﹤0.01%
+24
New +$42.2K
SIOX
12293
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$20K ﹤0.01%
57,187
-4,546
-7% -$1.88K
RMO
12294
PUT
DELISTED
Romeo Power, Inc.
RMO
$20K ﹤0.01%
43,900
-151,300
-78% -$142K
ALGS icon
12295
Aligos Therapeutics
ALGS
$44.1M
$19K ﹤0.01%
+641
New +$21.8K
CTXR icon
12296
PUT
Citius Pharmaceuticals
CTXR
$16.9M
$19K ﹤0.01%
820
+84
+11% +$2.3K
CYN icon
12297
Cyngn
CYN
$15.7M
$19K ﹤0.01%
+1
New +$28.9K
GRNQ icon
12298
Greenpro Capital
GRNQ
$23.7M
$19K ﹤0.01%
882
+377
+75% +$13.8K
PAVS icon
12299
Paranovus Entertainment Technology
PAVS
$4.65M
0
RDHL
12300
PUT
Redhill Biopharma
RDHL
$3.83M
$19K ﹤0.01%
22
-27
-55% -$37K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.